LEQEMBI IQLIK, approved by the U.S. FDA in August 2025, is the first and only anti-amyloid treatment to offer an at-home injection after initial treatment of 18 months ...
YouTube’s new program links advertisers and agencies with vetted third-party experts in media buying and campaign management.
Alphabet-owned ($GOOGL) search engine giant Google has launched a new partnership program for its streaming platform YouTube. The program expands ...
Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced an exclusive collaboration and in-licensing agreement (the Agreement) with QIMR Berghofer for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback